FDA pushes to make cigarettes less addictive
For the first time, the federal government is proposing cutting the nicotine level in cigarettes so they aren’t so addictive.
U.S. Food and Drug Administration chief Scott Gottlieb on Friday directed the agency’s staff to develop new regulations on nicotine. The FDA has had the power since 2009 to regulate nicotine levels but hasn’t done so. Stocks of cigarette makers plunged after the announcement.
Gottlieb also said the FDA is giving e-cigarette makers four more years to comply with a review of products already on the market.
“A renewed focus on nicotine can help us to achieve a world where cigarettes no longer addict future generations of our kids,” Gottlieb said in a speech to staff in Silver Spring, Maryland.
Tar and other substances inhaled through smoking make cigarettes deadly, but the nicotine in tobacco is what makes them addictive. Tobacco use is the leading cause of preventable heart disease, cancer and death in the United States, causing more than 480,000 deaths annually.
U.S. smoking rates have been falling for decades. They dropped from about 17 percent in 2014 to 15 percent in 2015, and held about steady at that level last year.
The FDA announcement is great news, said Eric Donny, a University of Pittsburgh researcher who has studied what happens when smokers puff on cigarettes with lower levels of nicotine.
Donny and other researchers found that reducing nicotine substantially — by around 90 percent — leads to smokers being less dependent on cigarettes and smoking fewer of them.
There have been concerns that smokers might react to lower nicotine levels by smoking more. But the research shows that’s not what happens — not if enough nicotine is taken out, Donny said.
“If you just reduce it a little, people might smoke more to make up the difference. They need to reduce it a lot,” Donny said.
Kenneth Warner, a retired University of Michigan public health professor who is a leading authority on smoking and health, said he was pleasantly surprised to learn of the FDA announcement.
“If you can separate the nicotine people are craving from the smoke that’s killing them, then you may be doing something very important,” Warner said.
Altria Group, which sells Marlboro and other cigarettes in the U.S., said it would be “fully engaged” in FDA’s rule-making process.
“Any proposed rule such as a nicotine product standard must be based on science and evidence, must not lead to unintended consequences and must be technically achievable,” the company said in a statement.